The RANK/RANKL/OPG triad in cancer-induced bone diseases

By Dougall William   Chaisson Michelle  

Cancer and Metastasis Reviews, Vol. 25, Iss. 4, 2006-12 ,pp. : 541-549

Springer Publishing Company

Access to resources Recommend Favorite

Activation of spinal neuregulin 1-ErbB2 signaling pathway in a rat model of cancer-induced bone pain

By          

International Journal of Oncology, Vol. 45, Iss. 1, 2014-01 ,pp. : 235-244

Spandidos Publications

Access to resources Recommend Favorite

Pharmacologic inhibition of bone resorption prevents cancer-induced osteolysis but enhances soft tissue metastasis in a mouse model of osteolytic breast cancer

By                                

International Journal of Oncology, Vol. 45, Iss. 2, 2014-01 ,pp. : 532-540

Spandidos Publications

Access to resources Recommend Favorite

Fasudil inhibits prostate cancer-induced angiogenesis in vitro

By  

Oncology Reports, Vol. 32, Iss. 6, 2014-01 ,pp. : 2795-2802

Spandidos Publications

Access to resources Recommend Favorite

Bone loss induced by cancer treatment and its management

By Delmas P.D.   Fontana A.  

European Journal of Cancer, Vol. 34, Iss. 2, 1998-02 ,pp. : 260-262

Elsevier

Access to resources Recommend Favorite